The transition of synthetic biology from academic confines to commercial implementation presents a formidable task. For synthetic biology to exert its profound influence, an escalation to industrial magnitude becomes imperative. This amplification journey is laden with challenges, encompassing aspects such as fermentation prowess, fiscal considerations, supply chain innovations, feedstock accessibility, and bioreactors' efficiency and design intricacies. Notwithstanding these hurdles, emergent technologies and methodologies are paving the way, poised to elevate the bioeconomy to unprecedented levels.

‍

Session Topics:

• Rubber, Meet Road: Getting Practical (and Realistic) About Biomanufacturing Scale-Up
• Building Biomanufacturing in Today’s Financial Market
• Commercialization Unlocked: How to Overcome Synbio's Core Scale-Up and Manufacturing Challenges
• SynBio Bottlenecks: Streamlining Data Standards
• Heads Up, Scale Up: The Hidden Costs of Outsourcing Bioprocess Development
• Bioeconomy Scale Up Through Bioprocess Innovation
• Digital Twins in Biomanufacturing: A New Horizon
• Hands On, High-T: Global Launch of End-to-End High-Throughput Process Development Platform
• Biomanufacturing Breakdown: Lessons Learned from Scale-Up Failures and Successes

‍

‍

‍